Imtiaz Ali’s filmography might be modest, but the director has garnered a dedicated fan base over the years. While currently engrossed in promoting his 9th film, Amar Singh Chamkila, the inevitable question about sequels to his fan favourites, Jab We Met and Love Aaj Kal, persistently follows him everywhere. In a recent interview with Pinkvilla, Imtiaz was asked about potential sequels to these two films.
While the filmmaker didn’t completely negate the possibility of the sequels, he admitted to not working on them anytime soon. He said, “No (laughs). No Love Aaj Kal 3 and no Jab We Met 2 as of now. I don’t know whether I should make a sequel. But I never say never, though there are no plans at present. Let’s see what happens. I have three scripts that I am crazily desperate to start making.”
Jab We Met marked a turning point in Imtiaz Ali’s career, establishing him as a prominent filmmaker. Since its release, the film has been an integral part of Bollywood’s pop culture, with Kareena Kapoor’s portrayal of the female lead Geet resonating deeply with audiences. Co-starring Shahid Kapoor, the movie remains a fan favourite to date. Similarly, Love Aaj Kal, featuring Deepika Padukone and Saif Ali Khan, enjoyed widespread acclaim and emerged as one of the highest-grossing films of 2009. While Imtiaz revisited the concept with a sequel starring Sara Ali Khan and Kartik Aaryan in 2020, it failed to replicate the fervour of its predecessor and garnered only moderate success at the box office.
As for Imtiaz’s upcoming project, Amar Singh Chamkila, the film delves into the life of the renowned Punjabi singer of the same name, who met a tragic end at the age of 27. Starring Diljit Dosanjh and Parineeti Chopra in lead roles, the film’s music is given by AR Rahman. It will be released on April 12 on Netflix.
Click for more updates and latest Bollywood news along with Entertainment updates. Also get latest news and top headlines from India and around the world at The Indian Express.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
